pscotti

Paul Scotti @pscotti

About Me

Organization Name
Mayo Clinic

Organization Country
United States

I have read and accept the Terms of Use for the site.
1

I will not release information before the embargo date provided for each resource.
1

Activity by Paul Scotti @pscotti

pscotti

Wed, Sep 7 at 11:00am EDT by @pscotti · View  

Mayo Clinic, UNF to Host 12th Annual Upbeat Pink Concert

Performers on stage for a breast cancer awareness concertJACKSONVILLE, Fla. – Mayo Clinic and the University of North Florida (UNF) are honoring National Breast Cancer Awareness Month in October by hosting the 12th annual “Upbeat Pink: A Musical Tribute to Breast Cancer Survivorship” concert on Friday, Oct. 14 at 7:30 p.m. in Lazzara Performance Hall, UNF Fine Arts Building on the university’s campus in Jacksonville, Florida. The Upbeat Pink concert is free and open to the public.

The theme for this year’s program, “Superheroes”, showcases the UNF Wind Symphony, which will be conducted by Gordon Brock, D.M.A. Music from such movies as “Wonder Woman”, “Superman”, “Batman”, “Spiderman”, “Star Wars” and others will be featured in the performance.

Guest speakers will include Shelly Brock, A.R.N.P, M.S.N, a nurse practitioner in the breast clinic at Mayo Clinic’s Florida campus and Jennifer Case, a breast cancer survivor.

The Upbeat Pink musical tribute is a prelude to the 10th-annual 26.2 with Donna: The National Marathon to Finish Breast Cancer, which is scheduled for Feb.12, 2017 in Jacksonville Beach, Florida. The marathon is the first devoted exclusively to raising funds for breast cancer research. Once again the Donna Foundation will donate most of the proceeds from the marathon to Mayo Clinic for breast cancer research. The 2016 event attracted more than 10,000 runners from around the world.

For more information about the Upbeat Pink concert, call the Breast Clinic in Florida at 904-953-0707 or visit the Breast Clinic’s Facebook events page.

###

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or http://newsnetwork.mayoclinic.org/.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 904-953-0199,  [email protected]

 

Login here to comment.
pscotti

Mon, Jun 13 at 9:15am EDT by @pscotti · View  

Advancing Field of Transplantation: Lifetime Honor for Dr. Gonwa

gonwa-3430371_0004

The American Society of Transplantation (AST) awarded its highest honor, the Lifetime Achievement Award, to Thomas Gonwa, M.D. at the recent American Transplant Congress in Boston. The Lifetime Achievement Award honors a senior investigator whose work has advanced the field of transplantation.

Dr. Gonwa came to Mayo Clinic in 2001, after leading renal and liver transplant programs at Baylor University Medical Center. He helped build the local transplant program in Jacksonville, Florida, which to date has done more than 5,600 solid organ transplants. Dr. Gonwa went on to serve as chair of the Department of Transplantation from 2006 through 2015.

Today he serves as associate director of Mayo Clinic’s Center for Regenerative Medicine in Florida.

Dr. Gonwa is an active clinical investigator, best known for his work on chronic kidney disease in patients undergoing liver transplantation. He has authored 188 original papers and 10 book chapters.

The AST represents more than 3,300 transplantation professionals dedicated to advancing the field and improving patient care by promoting research, education, advocacy, and organ donation.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 507-284-5005, [email protected]

Login here to comment.
pscotti

Mon, Mar 28 at 9:00am EDT by @pscotti · View  

Florida Completes 3000 Liver Transplants

exterior of Mayo Clinic hospital entrance in Florida

The liver transplant team at Mayo Clinic in Jacksonville, Florida, recently completed the 3,000th transplant since the liver program started in 1998. Mayo Clinic’s Florida campus is only the seventh transplant center in the country to complete 3,000 adult liver transplants.

Mayo Clinic’s Florida campus has one of the largest liver transplant programs in the country. The combined volume of the liver transplant program at Mayo Clinic’s campuses in Arizona, Florida and Minnesota makes it the largest overall program in the country. To date, 6,681 liver transplants have been completed at Mayo Clinic’s campuses in Arizona, Florida and Minnesota. The Florida campus leads the way with the most liver transplants.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 507-284-5005, [email protected]

“Our team is pleased to be a leading liver transplant center in the country and is proud of reaching this current milestone,” says Dr. C.Burcin Taner, chair of the Transplant program on Mayo Clinic’s Florida campus. “The effort of our team is not only reflected in the volume, but also in the quality of the care we provide.” One of the hallmarks of the Florida program is above-average three-year survival rates for liver transplant patients.

“Florida’s observed three-year survival rate is statistically better than expected and when compared to the national average,” says Dr. Taner. Nationally, about 82 percent of patients achieve three-year survival. Florida boasts a three-year patient survival of almost 90 percent.

“As we look to the future, for us to continue our work and save lives, we need everyone to consider being an organ donor and give the gift of life to someone in need,” Dr. Taner says.  In the U.S., there are almost 15,000 patients on the waiting list for a new liver.

Journalists: Sound bites with Dr. Taner are in the downloads.

Login here to comment.
pscotti

Tue, Mar 1 at 10:15am EDT by @pscotti · View  

Mayo Clinic to Host its First Public Cancer Education Symposium in Orlando

light in person's hands in cupped shapeORLANDO, Fla. - The Mayo Clinic Cancer Center will host “Capture the Moment,” a public cancer education symposium at the Ritz Carlton at Orlando Grande Lakes, Florida, on Saturday, March 12 from 7 a.m. to 6 p.m. The symposium will inform the public on a broad range of cancer-related topics. It is the first time that the Mayo Clinic Cancer Center has hosted this type of public cancer education program in the Orlando area.

The symposium features a large general session in the morning, followed by disease-specific breakouts and small group sessions in the afternoon. The program will address unmet needs that patients and their loved ones have relating to a cancer diagnosis, but rarely are discussed in the exam room. Cancer experts from Mayo Clinic’s campuses in Florida, Arizona and Minnesota, as well as local guest speakers, will address topics that will empower patients and caregivers to help them better understand their cancer treatment. Topics include cancer treatment options, precision medicine, the role of nutrition and exercise, cancer survivorship, clinical trials, financial and legal challenges, and spirituality.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 904-953-0199, [email protected]

“The goal of this symposium is to equip and empower patients with the educational tools to better cope with the diagnosis and treatment of cancer,” says Winston Tan, M.D., course director and an oncologist at Mayo Clinic’s Florida campus. “It is designed for cancer patients, survivors, caregivers and family members who are interested in learning more about cancer and the role they play in survivorship and education.”Pages-from-Capture_the_Moment_FL

 

The event is free and open to the general public, however, registration is required. Seating is available on a first-come, first-served basis. Register now at [email protected]  or http://www.mayoclinic.org/floridacancersymposium.

About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, the Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 1-855-776-0015 (toll-free).

# # # #

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org or http://newsnetwork.mayoclinic.org.

 

Login here to comment.
pscotti

Wed, Jan 27 at 9:00am EDT by @pscotti · View  

Jacoby Center for Breast Health Opens in Florida

woman in tshirt making heart symbol with hands and pink ribbon, representing breast health
JACKSONVILLE, Fla. – Mayo Clinic’s Florida campus today announced the opening of the Robert and Monica Jacoby Center for Breast Health, which was funded by a $5 million gift from Robert E. and Monica Jacoby of Ponte Vedra, Florida. The new 16,000-square-foot  multidisciplinary breast center offers patients a comprehensive array of diagnostic, treatment and after-care services for all types of breast disease, including breast cancer, in a single location.

placque, Jacoby Center for Breast Health; Florida“As a state-designated Cancer Center of Excellence, Mayo Clinic continues to expand and enhance comprehensive cancer care services to make them available to more patients in Jacksonville as well as all of Florida and the Southeast,” says Gianrico Farrugia, M.D., CEO, Mayo Clinic in Florida. “The Jacoby Center for Breast Health will have a positive impact on patients seeking high quality breast health care. We greatly appreciate the generous gift from the Jacoby family that has made the new breast health center possible on our Florida campus.”

Robert and Monica Jacoby are long-standing patients and benefactors of Mayo Clinic whose gifts to the institution have exceeded $10 million.  In addition to the new breast health center, the cardiology suite in Mayo Clinic hospital is named to recognize their generosity. For more than a decade, the Jacoby’s were members of the Mayo Clinic Leadership Council in Florida, serving as ambassadors and advocates of philanthropy.

Journalists: Sound bites with Dr. Sarah McLaughlin, breast center director, are available in the downloads. B'roll of the new center and other related content is also available in the downloads.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 507-284-5005, [email protected]

As the parents of four daughters, the Jacobys are dedicated to fighting breast cancer. “We want people to know there’s hope,” says Mrs. Jacoby. “From our own experience, we’re convinced Mayo Clinic is the best place to deliver that hope.”

Located on the second floor of the Davis Building on the Mayo Clinic campus at 4500 San Pablo Road, the new breast center features a clinical and support staff of approximately 50 people. They include women’s breast health specialists, breast oncology surgeons, plastic surgeons, breast radiologists, breast medical oncologists, breast radiation oncologists, genetic counselors, breast mammography technicians, nurse navigators and nurses.

Locating all breast sub-specialties in one common area enables specialty consultants to be more readily available to discuss complex cases and meet with patients to explain the sequence of their care. It also allows for a more effective means of scheduling patients, reducing wait times for appointments. The new breast health center provides patients with a serene environment where only patients with similar disorders are evaluated. The full integration of clinical services and research also improves patient access to the latest Mayo Clinic breast-related clinical trials.doctor speaking to patient; Jacoby Center for Breast Health; Florida

“The Jacoby Center for Breast Health is the most comprehensive, multidisciplinary breast health facility in Northeast Florida,” says Sarah McLaughlin, M.D., a Mayo Clinic breast surgeon and director of the new breast center. “It allows for true integration and efficiency of care, as patients can now access breast health experts from virtually every related medical discipline in one location, from genetic testing, breast imaging and diagnosis to oncology care, surgery, plastic surgery and after-care support.”

Mayo Clinic‘s cancer program initiatives include a recently announced collaboration with St. Vincent’s Healthcare to provide expanded Mayo Clinic cancer care services to residents of Northeast Florida. Mayo Clinic also continues its nine-year relationship with the 26.2 with Donna Marathon, which helps fund breast cancer genomics research at Mayo Clinic’s Florida campus.

The Mayo Clinic Cancer Center is the only comprehensive cancer center in Northeast Florida designated by the National Cancer Institute and 1 of only 2 in the state. Mayo Clinic also is 1 of only 4 institutions in Florida designated by the state as a Cancer Center of Excellence and is nationally ranked in cancer in the U.S. News & World Report annual survey of more than 5,000 hospitals.

For more information, call the new Jacoby Center for Breast Health at 904-953-0707.

#  #  #  #

About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, the Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 1-855-776-0015 (toll-free).

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit mayoclinic.org or newsnetwork.mayoclinic.org.

Login here to comment.
pscotti

Sep 1, 2015 by @pscotti · View  

Mayo Clinic, University of North Florida to host 11th annual Upbeat Pink: A Musical Tribute to Breast Cancer Survivorship

pink ribbon with sign that says breast cancer awarenessJACKSONVILLE, Fla. – Mayo Clinic and the University of North Florida (UNF) are honoring National Breast Cancer Awareness Month in October by hosting the 11th annual “Upbeat Pink: A Musical Tribute to Breast Cancer Survivorship” concert on Friday, Oct. 9 at 7:30 p.m. in Lazzara Performance Hall, UNF Fine Arts Building on the university’s campus in Jacksonville. The Upbeat Pink concert is free and open to the public.

The theme for this year’s program, “The Wild West Through TV and Movies”, showcases the UNF Wind Symphony, which will be conducted by Gordon Brock, D.M.A.

Guest speakers will include Stephanie Hines, M.D. from Mayo Clinic’s Florida campus and Patricia Dunbar-Norris, a breast cancer survivor.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 507-284-5005, [email protected] [...]

Click here to view the rest of the post

Login here to comment.
pscotti

May 30, 2015 by @pscotti · View  

Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers

CHICAGO — Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.

Led by Mayo Clinic, researchers found that ibrutinib and chemotherapy (bendamustine and rituximab, known as BR) reduced the risk of death or cancer progression by almost 80 percent in patients with previously treated CLL or SLL, compared to use of BR alone.

MEDIA CONTACTS:
Joe Dangor (on-site at ASCO), Mayo Clinic Public Affairs, 651-261-9089 (cell), [email protected].
Paul Scotti, Mayo Clinic Public Affairs, 904-953-0199 (office), [email protected].

[...]

Click here to view the rest of the post

Login here to comment.
pscotti

May 28, 2015 by @pscotti · View  

Mayo Clinic in Florida Receives Highest Nursing Designation

Mayo Building and Hospital, Jacksonville, FL

Mayo Building and Hospital, Jacksonville, FL

JACKSONVILLE, Fla. — Mayo Clinic’s Florida campus has been recognized by the American Nurses Credentialing Center (ANCC) with a Magnet Recognition Program® designation. This credential recognizes health care organizations for quality patient care, nursing excellence and innovations in professional nursing practice. Mayo Clinic is one of only 20 hospitals in Florida and 401 nationally with Magnet Recognition Program status.

In the nursing profession, Magnet recognition is considered the gold seal that epitomizes the importance of quality, safety and improvement; intradisciplinary and interdisciplinary teamwork; understanding of evidence based practice and research; and formal nursing education. It requires organizations to develop, disseminate and enculturate evidenced-based criteria that results in a positive work environment for nurses and, by extension, all employees. U.S. News & World Report includes the Magnet designation as a primary competence indicator in its assessment of almost 5,000 hospitals to rank and report the best medical centers in 16 specialties.

[...]

Click here to view the rest of the post

Login here to comment.
pscotti

May 19, 2015 by @pscotti · View  

Livers Donated after Cardiac Death Safe to Use in Liver Cancer Patients

JACKSONVILLE, Fla. — Patients with liver cancer can be cured with a liver transplant. But because of the shortage of donated organs, these patients often die waiting for a liver. That’s because most transplant centers predominantly use livers from donors who die from brain death.

But in the largest study of its kind, transplant physicians at Mayo Clinic in Florida have found that liver cancer patients have the same beneficial outcomes using organs donated by patients who died of cardiac death. The study was recently published online in the American Journal of Transplantation.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 904-953-0199, [email protected]

[...]

Click here to view the rest of the post

Login here to comment.
pscotti

Dec 8, 2014 by @pscotti · View  

Immune Function Marker Does Not Predict Benefit of Trastuzumab in HER-2+ Breast Cancer Patients, Study Finds

JACKSONVILLE, Fla. — A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with chemotherapy for HER2-positive breast cancer. But that marker — the quantity of tumor-infiltrating lymphocytes (S-TILs) in a biopsy — appears irrelevant when trastuzumab is used.

[...]

Click here to view the rest of the post

Login here to comment.
pscotti

Nov 9, 2014 by @pscotti · View  

Combination Therapy Offers Quicker, Less Toxic Eradication of Hepatitis C in Patients with Transplanted Livers

JACKSONVILLE, Fla., Nov. 9, 2014 — All patients with hepatitis C who receive a liver transplant will eventually infect their new livers. These transplanted organs then require anti-viral treatment before they become severely damaged. But traditional post-transplant hepatitis C therapy can take up to a year, is potentially toxic and can lead to organ rejection.

Now, at the American Association for the Study of Liver Diseases (The Liver Meeting® 2014) in Boston, researchers at Mayo Clinic report that use of two new oral medications post-transplant is safe and beneficial, and requires only 12 weeks of treatment.

“This is the first study to examine the use of these two new drugs — simeprevir and sofosbuvir — in liver transplant recipients, and, based on this large study, we find it to be a better option than current treatment,” says the study’s lead researcher, Surakit Pungpapong, M.D., a transplant hepatologist and an associate professor of medicine at Mayo Clinic in Florida.

Journalists: Soundbites with Dr. Pungpapong are available in the downloads.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 904-953-0199. Email: [email protected] [...]

Click here to view the rest of the post

Login here to comment.
pscotti

Oct 21, 2014 by @pscotti · View  

Trastuzumab (Herceptin) Continues to Show Life-Altering Benefit

large crowd of women in pink t shirts for breast cancer awareness


Years After Treatment for HER2-Positive Early Stage Breast Cancer Trastuzumab Shows Life-Altering Benefit 

JACKSONVILLE, Fla. — After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free survival of women with early stage HER2-positive breast cancer.

They found that the use of trastuzumab produced a 37 percent improvement in survival and a 40 percent reduction in risk of cancer occurrence, compared to patients treated with chemotherapy alone.

These findings, published in the Journal of Clinical Oncology, demonstrate how important trastuzumab has been to the treatment of this form of breast cancer, says the study’s lead author, Edith A. Perez, M.D., deputy director at large, Mayo Clinic Cancer Center and director of the Breast Cancer Translational Genomics Program at Mayo Clinic in Florida. [...]

Click here to view the rest of the post

Login here to comment.
pscotti

Sep 30, 2014 by @pscotti · View  

Dados de estudos clínicos mundiais de dois medicamentos para câncer de mama HER2-positivo mostra que o trastuzumabe deve permanecer como o padrão de tratamento

JACKSONVILLE, Flórida 30 de setembro de 2014 — Análises em mais de 8 mil mulheres, que participaram do maior estudo mundial de dois medicamentos para o câncer de mama HER2-positivo, reforçam outras descobertas de estudos clínicos mostrando que o trastuzumabe (Herceptin) deve permanecer como o padrão de tratamento desse tipo de câncer, diz uma pesquisadora da Clínica Mayo. [...]

Click here to view the rest of the post

Login here to comment.
pscotti

Sep 30, 2014 by @pscotti · View  

Datos de un ensayo clínico realizado a nivel mundial con dos fármacos contra el cáncer de mama HER2-positivo muestran que el trastuzumab debería permanecer como tratamiento estándar

JACKSONVILLE, Florida, 30 de septiembre 2014 — Investigaciones en más de 8.000 mujeres, que participaron en el estudio más grande del mundo de dos tratamientos para el cáncer de mama HER2-positivo, refuerzan otros hallazgos de este ensayo clínico que demuestran que el fármaco trastuzumab (Herceptin) debiera seguir siendo el tratamiento estándar en este tipo de cáncer, expresa una investigadora de la Clínica Mayo. [...]

Click here to view the rest of the post

Login here to comment.
pscotti

Sep 29, 2014 by @pscotti · View  

Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care

JACKSONVILLE, Fla., Sept. 29, 2014 — Analysis of more than 8,000 women who participated in the world’s largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that trastuzumab (Herceptin) should remain the standard of care for this cancer, says a Mayo Clinic researcher.

[...]

Click here to view the rest of the post

Login here to comment.
pscotti

Sep 12, 2014 by @pscotti · View  

Physicians Find Liver Transplant Patients Can Avoid Costly Stay In ICU Post Surgery

JACKSONVILLE, Fla., Sept. 12, 2014 — The liver transplant team at Mayo Clinic in Florida has found, based on 12 years of experience, that more than half of patients receiving a new liver can be “fast-tracked” to return to a surgical ward room following their transplant, bypassing a one- or two-day stay in the Intensive Care Unit (ICU).

In the September issue of the American Journal of Transplantation, the physicians and researchers have turned their knowledge of who can be safely fast-tracked into a scoring system that other transplant centers can also use — thus sparing patients potentially overly aggressive treatment and saving substantial health care dollars.

MEDIA CONTACT: Paul Scotti, Mayo Clinic Public Affairs, 904-953-0199. Email: [email protected]

[...]

Click here to view the rest of the post

Login here to comment.
pscotti

Sep 2, 2014 by @pscotti · View  

Mayo Clinic, University of North Florida Host Tenth Annual Upbeat Pink: A Musical Tribute to Breast Cancer Survivorship

JACKSONVILLE, Fla., Sept. 2, 2014 – Mayo Clinic and the University of North Florida are honoring Upbeat Pink ConcertNational Breast Cancer Awareness Month in October by hosting the tenth annual “Upbeat Pink: A Musical Tribute to Breast Cancer Survivorship” concert on Friday, Oct. 10 at 7:30 p.m. in Lazzara Performance Hall, UNF Fine Arts Building on the university’s campus in Jacksonville. The Upbeat Pink concert is free and open to the public.

The theme for this year’s program, “Dancing with the Survivors,” showcases a variety of dance music performed by the UNF Wind Symphony, conducted by Gordon Brock, D.M.A., and features special guest artist and multi-instrumentalist,  Bill Prince, D.M.A.

Guest speakers will include Laura Vallow, M.D., radiation oncologist at Mayo Clinic and Dianne Wagner, a local breast cancer survivor.
[...]

Click here to view the rest of the post

Login here to comment.
pscotti

Jun 5, 2014 by @pscotti · View  

Estudo ALTTO sobre terapia combinada anti HER2, no Câncer de Mama, indica que um único agente, o Trastuzumabe, permanece como o padrão ouro de tratamento

CHICAGO — No maior estudo clínico já realizado para analisar a eficácia do tratamento do câncer de mama HER2 positivo, com um ou com a combinação de dois medicamentos, os pesquisadores relataram que o uso do lapatinibe (Tykerb) não apresentou  benefício ao tratamento auxiliar padrão com trastuzumabe (Herceptin), conforme apresentado durante o  50º encontro anual da Sociedade Americana de Oncologia Clínica (ASCO — American Society of Clinical Oncology).

Resultados do estudo clínico de fase III ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Study) demonstraram que ao acrescentar lapatinibe ao tratamento com trastuzimabe e quimioterapia não melhorou os resultados gerais para os pacientes (definidos como sobrevida livre da doença ou sobrevida total) e que o uso de lapatinibe aumentou de forma significativa a toxicidade do tratamento. [...]

Click here to view the rest of the post

Login here to comment.
pscotti

Jun 5, 2014 by @pscotti · View  

Cáncer de mama: Estudio ALTTO sobre terapia combinada anti HER2, encuentra que agente único — el Trastuzumab — sigue siendo el mejor tratamiento estándar

CHICAGO — En el mayor estudio clínico que prueba la eficacia de un tratamiento versus dos drogas para tratar el cáncer de mama HER2-positivo, lapatinib (Tykerb ) no agregó beneficio en relación a la terapia adyuvante estándar, trastuzumab (Herceptin), según informan investigadores de la 50a reunión anual de la Sociedad Americana de Oncología Clínica (ASCO).

Los resultados del ensayo clínico de fase III, ALTTO (Estudio de Optimización de Tratamiento Adyuvante Lapatinib y/o Trastuzumab), demostraron que agregando lapatinib a trastuzumab y quimioterapia no mejoró el resultado del paciente (definido como supervivencia libre de enfermedad o supervivencia sin progresión de ésta),  y que el uso de lapatinib incrementó significativamente la toxicidad del tratamiento. [...]

Click here to view the rest of the post

Login here to comment.
pscotti

Jun 5, 2014 by @pscotti · View  

Tamanho do tumor é fator determinante para resposta a tratamento com medicamento promissor para tratamento de melanoma

CHICAGO — Ao examinar porque alguns pacientes com melanoma avançado respondem tão bem à imunoterapia experimental MK-3475, enquanto outros obtêm uma resposta mais fraca, pesquisadores da Clínica Mayo de Jacksonville, na Flórida, descobriram que o tamanho dos tumores, antes do tratamento, era a variável mais forte. [...]

Click here to view the rest of the post

Login here to comment.
Loading information...